Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning
Background - Salvage radiotherapy (SRT) is the standard treatment for biochemical recurrence (bREC) after radical prostatectomy (RP), yet optimal radiation dose, field size, and the role of advanced imaging like PSMA-PET remain unclear. This study assessed the impact of SRT dose and the prognostic r...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 2025
|
| In: |
Radiotherapy and oncology
Year: 2025, Jahrgang: 212, Pages: 1-7 |
| ISSN: | 1879-0887 |
| DOI: | 10.1016/j.radonc.2025.111113 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.radonc.2025.111113 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814025046171 
|
| Verfasserangaben: | Federica Medici, Daniel M. Aebersold, Jozefina Casuscelli, Louise Emmett, Stefano Fanti, Andrea Farolfi, Matthias Guckenberger, George Hruby, Stefan A. Koerber, Stephanie A. Thoma, Jan C. Peeken, Paul Rogowski, Sophia Scharl, Mohamed Shelan, Simon K.B. Spohn, Iosif Strouthos, Marco Vogel, Thomas Wiegel, Constantinos Zamboglou, Nina-Sophie Schmidt-Hegemann, Alessio G. Morganti, Savino Cilla |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 195119604X | ||
| 003 | DE-627 | ||
| 005 | 20260205111058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260205s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2025.111113 |2 doi | |
| 035 | |a (DE-627)195119604X | ||
| 035 | |a (DE-599)KXP195119604X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Medici, Federica |e VerfasserIn |0 (DE-588)1389047652 |0 (DE-627)1951200519 |4 aut | |
| 245 | 1 | 0 | |a Refining prognostic stratification in salvage radiotherapy for prostate cancer |b a retrospective multicenter cohort study using PSMA-PET and machine learning |c Federica Medici, Daniel M. Aebersold, Jozefina Casuscelli, Louise Emmett, Stefano Fanti, Andrea Farolfi, Matthias Guckenberger, George Hruby, Stefan A. Koerber, Stephanie A. Thoma, Jan C. Peeken, Paul Rogowski, Sophia Scharl, Mohamed Shelan, Simon K.B. Spohn, Iosif Strouthos, Marco Vogel, Thomas Wiegel, Constantinos Zamboglou, Nina-Sophie Schmidt-Hegemann, Alessio G. Morganti, Savino Cilla |
| 264 | 1 | |c November 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar 21 August 2025, Version des Artikels 2 September 2025 | ||
| 500 | |a Gesehen am 05.02.2026 | ||
| 520 | |a Background - Salvage radiotherapy (SRT) is the standard treatment for biochemical recurrence (bREC) after radical prostatectomy (RP), yet optimal radiation dose, field size, and the role of advanced imaging like PSMA-PET remain unclear. This study assessed the impact of SRT dose and the prognostic role of PSMA-PET on 2-year biochemical relapse-free survival (bRFS) in patients with localized disease. - Methods - In this retrospective multicenter study, 255 patients treated with SRT across 11 centers were selected from a database of 1,201 cases. Inclusion criteria included PSA persistence/recurrence (≥0.1 ng/mL) post-RP and negative PSMA-PET for nodal or distant metastases. Patients receiving androgen deprivation therapy or with PSA > 0.5 ng/mL pre-SRT were excluded. Prognostic factors were identified using LASSO analysis and modeled with CART analysis. The primary endpoint was 2-year bRFS. - Results - With a median follow-up of 33 months, 2-year bRFS was 88.2 %. Lower pre-SRT PSA (<0.2 ng/mL), PSMA-PET negativity, longer PSA doubling time, older age, favorable ISUP grades (1-2), and shorter intervals from surgery to bREC were associated with improved bRFS. CART analysis demonstrated that PSMA-PET findings significantly influenced prognosis in patients with PSA levels below 0.2 ng/mL, while PSA-doubling time was predictive in patients with PSA 0.2-0.5 ng/mL. SRT dose and elective nodal irradiation did not significantly affect bRFS. - Conclusions - This study underscores the complexity of prognostic modeling in SRT for prostate cancer, highlighting the value of PSMA-PET and CART for refined risk stratification. | ||
| 650 | 4 | |a Androgen deprivation therapy | |
| 650 | 4 | |a Biochemical recurrence | |
| 650 | 4 | |a Biochemical relapse-free survival | |
| 650 | 4 | |a ISUP grade | |
| 650 | 4 | |a Metastasis-free survival | |
| 650 | 4 | |a Pathological T stage | |
| 650 | 4 | |a Prognostic factors | |
| 650 | 4 | |a Prophylactic lymph node irradiation | |
| 650 | 4 | |a Prostate cancer | |
| 650 | 4 | |a PSMA-PET | |
| 650 | 4 | |a Radical prostatectomy | |
| 650 | 4 | |a Radiotherapy dosing | |
| 650 | 4 | |a Salvage radiotherapy | |
| 650 | 4 | |a Therapeutic intensification | |
| 700 | 1 | |a Aebersold, Daniel M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Casuscelli, Jozefina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Emmett, Louise |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fanti, Stefano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Farolfi, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Guckenberger, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hruby, George |e VerfasserIn |4 aut | |
| 700 | 1 | |a Körber, Stefan A. |e VerfasserIn |0 (DE-588)1023031140 |0 (DE-627)717350053 |0 (DE-576)366291823 |4 aut | |
| 700 | 1 | |a Thoma, Stephanie A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Peeken, Jan C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rogowski, Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scharl, Sophia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shelan, Mohamed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Spohn, Simon K. B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Strouthos, Iosif |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vogel, Marco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wiegel, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zamboglou, Constantinos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmidt-Hegemann, Nina-Sophie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morganti, Alessio G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cilla, Savino |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Radiotherapy and oncology |d Amsterdam [u.a.] : Elsevier Science, 1983 |g 212(2025) vom: Nov., Artikel-ID 111113, Seite 1-7 |h Online-Ressource |w (DE-627)306710110 |w (DE-600)1500707-8 |w (DE-576)082435731 |x 1879-0887 |7 nnas |a Refining prognostic stratification in salvage radiotherapy for prostate cancer a retrospective multicenter cohort study using PSMA-PET and machine learning |
| 773 | 1 | 8 | |g volume:212 |g year:2025 |g month:11 |g elocationid:111113 |g pages:1-7 |g extent:7 |a Refining prognostic stratification in salvage radiotherapy for prostate cancer a retrospective multicenter cohort study using PSMA-PET and machine learning |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2025.111113 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0167814025046171 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260205 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1023031140 |a Körber, Stefan A. |m 1023031140:Körber, Stefan A. |d 50000 |e 50000PK1023031140 |k 0/50000/ |p 9 | ||
| 999 | |a KXP-PPN195119604X |e 4876909946 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Federica Medici, Daniel M. Aebersold, Jozefina Casuscelli, Louise Emmett, Stefano Fanti, Andrea Farolfi, Matthias Guckenberger, George Hruby, Stefan A. Koerber, Stephanie A. Thoma, Jan C. Peeken, Paul Rogowski, Sophia Scharl, Mohamed Shelan, Simon K.B. Spohn, Iosif Strouthos, Marco Vogel, Thomas Wiegel, Constantinos Zamboglou, Nina-Sophie Schmidt-Hegemann, Alessio G. Morganti, Savino Cilla"]},"language":["eng"],"recId":"195119604X","person":[{"given":"Federica","display":"Medici, Federica","role":"aut","family":"Medici"},{"given":"Daniel M.","display":"Aebersold, Daniel M.","role":"aut","family":"Aebersold"},{"role":"aut","family":"Casuscelli","given":"Jozefina","display":"Casuscelli, Jozefina"},{"given":"Louise","display":"Emmett, Louise","family":"Emmett","role":"aut"},{"display":"Fanti, Stefano","given":"Stefano","family":"Fanti","role":"aut"},{"given":"Andrea","display":"Farolfi, Andrea","role":"aut","family":"Farolfi"},{"family":"Guckenberger","role":"aut","given":"Matthias","display":"Guckenberger, Matthias"},{"role":"aut","family":"Hruby","given":"George","display":"Hruby, George"},{"display":"Körber, Stefan A.","given":"Stefan A.","family":"Körber","role":"aut"},{"given":"Stephanie A.","display":"Thoma, Stephanie A.","role":"aut","family":"Thoma"},{"role":"aut","family":"Peeken","given":"Jan C.","display":"Peeken, Jan C."},{"role":"aut","family":"Rogowski","given":"Paul","display":"Rogowski, Paul"},{"given":"Sophia","display":"Scharl, Sophia","family":"Scharl","role":"aut"},{"role":"aut","family":"Shelan","given":"Mohamed","display":"Shelan, Mohamed"},{"role":"aut","family":"Spohn","given":"Simon K. B.","display":"Spohn, Simon K. B."},{"role":"aut","family":"Strouthos","display":"Strouthos, Iosif","given":"Iosif"},{"family":"Vogel","role":"aut","display":"Vogel, Marco","given":"Marco"},{"family":"Wiegel","role":"aut","given":"Thomas","display":"Wiegel, Thomas"},{"family":"Zamboglou","role":"aut","given":"Constantinos","display":"Zamboglou, Constantinos"},{"given":"Nina-Sophie","display":"Schmidt-Hegemann, Nina-Sophie","family":"Schmidt-Hegemann","role":"aut"},{"role":"aut","family":"Morganti","given":"Alessio G.","display":"Morganti, Alessio G."},{"display":"Cilla, Savino","given":"Savino","family":"Cilla","role":"aut"}],"note":["Online verfügbar 21 August 2025, Version des Artikels 2 September 2025","Gesehen am 05.02.2026"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Refining prognostic stratification in salvage radiotherapy for prostate cancer","title":"Refining prognostic stratification in salvage radiotherapy for prostate cancer","subtitle":"a retrospective multicenter cohort study using PSMA-PET and machine learning"}],"id":{"eki":["195119604X"],"doi":["10.1016/j.radonc.2025.111113"]},"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"relHost":[{"recId":"306710110","id":{"zdb":["1500707-8"],"eki":["306710110"],"issn":["1879-0887"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Radiotherapy and oncology","title":"Radiotherapy and oncology","subtitle":"journal of the European Society for Therapeutic Radiology and Oncology"}],"origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"Amsterdam [u.a.]"}],"part":{"volume":"212","year":"2025","text":"212(2025) vom: Nov., Artikel-ID 111113, Seite 1-7","pages":"1-7","extent":"7"},"language":["eng"],"note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"pubHistory":["1.1983 -"],"disp":"Refining prognostic stratification in salvage radiotherapy for prostate cancer a retrospective multicenter cohort study using PSMA-PET and machine learningRadiotherapy and oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"The green journal"}]}],"origin":[{"dateIssuedDisp":"November 2025","dateIssuedKey":"2025"}]} | ||
| SRT | |a MEDICIFEDEREFININGPR2025 | ||